Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis.
Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stenning S, Pierart M, Van Glabbeke M. Karim AB, et al. Among authors: schraub s. Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):316-24. doi: 10.1016/s0360-3016(01)02692-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872276 Clinical Trial.
The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report.
Begg AC, Hofland I, Moonen L, Bartelink H, Schraub S, Bontemps P, Le Fur R, Van Den Bogaert W, Caspers R, Van Glabbeke M, et al. Begg AC, et al. Among authors: schraub s. Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1449-53. doi: 10.1016/0360-3016(90)90357-p. Int J Radiat Oncol Biol Phys. 1990. PMID: 2262369 Clinical Trial.
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.
van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmström PO, Collette L, Piérart M, Mirimanoff R, Karim AB; EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council. van den Bent MJ, et al. Among authors: schraub s. Lancet. 2005 Sep 17-23;366(9490):985-90. doi: 10.1016/S0140-6736(05)67070-5. Lancet. 2005. PMID: 16168780 Clinical Trial.
The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects.
Van den Bogaert W, van der Schueren E, Horiot JC, De Vilhena M, Schraub S, Svoboda V, Arcangeli G, de Pauw M, Van Glabbeke M. Van den Bogaert W, et al. Among authors: schraub s. Radiother Oncol. 1995 May;35(2):91-9. doi: 10.1016/0167-8140(95)01538-r. Radiother Oncol. 1995. PMID: 7569030 Clinical Trial.
Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer.
van den Bogaert W, van der Schueren E, Horiot JC, Chaplain G, Devilhena M, Raposo S, Leonor J, Schraub S, Chenal C, Barthelme E, et al. van den Bogaert W, et al. Among authors: schraub s. Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):587-91. doi: 10.1016/0360-3016(86)90067-2. Int J Radiat Oncol Biol Phys. 1986. PMID: 3516953 Clinical Trial.
160 results